Digital PCR Market to Reach USD 799.1 Million by 2026: Introduction of Devices such as Crystal dPCR will Add Impetus to Market

The global “Digital PCR” Market is forecast to reach USD 799.1 million by 2026, attributed to the increasing prevalence of infectious diseases and genetic disorders worldwide. Digital PCR is the biotechnological advancement of conventional PCR and provides a reproducible and sensitive method of measuring the amount of RNA or DNA in a sample. Fortune Business Insights discusses the market and its growth trajectories in a recently published report titled, “Digital PCR Market Size, Share & Industry Analysis, By Type (Droplet Digital PCR, Chip-based Digital PCR, and Others), By Product (Instruments and Reagents & Consumables), By Indication (Infectious Diseases, Oncology, Genetic Disorders, and Others), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Diagnostic Centers, and Academic & Research Organizations), and Regional Forecast, 2019-2026”.

According to this report, the market value was USD 224.9 million in 2018 and is likely to exhibit a CAGR of 17.2% within the forecast period of 2019 to 2026.

The report includes thorough compilation of the quantitative analysis of the industry for the period of 12 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period. This study includes a widespread analysis of the key segments of the industry. This analysis sheds light in the current trends and opportunities in the Digital PCR Market.

Request a Sample Copy of the Research Report: 

https://www.fortunebusinessinsights.com/enquiry/sample/digital-pcr-market-102014

Significant Industry Developments of the Digital PCR Market Include:

 

January 2019 – A new series of digital PCR platform was launched by QIAGEN. This platform is based on the combined assay development expert technology of Qiagen and FORMULATRIX.

 

October 2019 dd-Check STEC Solution was launched by Bio-Rad Laboratories, Inc. for the detection of virulence genes from Shiga toxin-producing Escherichia coli (STEC).

What does the Report Include?

The market report includes quantitative and qualitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers the different regions, which are contributing to the growth of the market. It includes the competitive landscape that involves leading companies and adoption of strategies by them to introduce new products, announce partnerships, and collaboration that will contribute to the growth of the market between 2020 and 2027. Moreover, the research analyst has adopted several research methodologies such as PESTEL and SWOT analysis to extract information about the current trends and industry developments that will drive the market growth in the forthcoming years.

Bio-Rad, Sysmex Inostics, and Thermo Fisher to Hold Dominant Shares with Diverse Portfolio

 

The global digital PCR market is consolidated in nature owing to the presence of many players. Companies such as Thermo Fisher Scientific Inc., Sysmex Inostics, and Bio-Rad Laboratories, Inc., are holding majority shares in the market on account of their diverse portfolio of chip-based digital PCR and droplet digital PCR and continuous launch of innovative technologies by these companies at large. Other players operating in this market are emphasizing on mergers and acquisitions, contracts and agreements, or other collaborative methods to attract high digital PCR market revenue and attain a significant position in the market in the coming years.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

For more information in the analysis of this report, visit: 

https://www.fortunebusinessinsights.com/digital-pcr-market-102014

Key Points of the Digital PCR Market Report:

  • The report provides a basic overview of the industry including its definition, applications, and manufacturing technology.
  • The report also explores the major international players in detail. In this part, the report presents the company profile, product specifications, capacity, and production value along with the market shares for each company.
  • Through the statistical analysis, the study depicts the global market including capacity, production, production value, cost/profit, and supply/demand from an international perspective.
  • Considering segmentation, the market is divided in terms of product, end-use, company, region, and other important aspects. Each of these categories forms an important base point for the competitive landscape analysis.
  • The report then estimates the market development and trends of the Digital PCR Market.

Rise in Prevalence of Genetic Disorders to Aid in Expansion of Market

The increasing prevalence of infectious and genetic diseases is a major digital polymerase chain reaction market growth driver. In addition to this, the advancement in medical technology and introduction of innovative devices for therapeutic purposes will also aid in expansion of the market in the coming years. These innovative devices include crystal dPCR, beam dPCR chip-based digital PCR, and droplet digital PCR.

On the other side, high cost of digital polymerase chain reaction installation may pose a major challenge to the market growth. This, coupled with the lack of awareness about the availability of treatment options, especially in developing and under-developed nations, may hamper the overall market in the coming years.Nevertheless, the gradual shift towards chip-based dPCR from droplet dPCR by healthcare providers is expected to boost the market in the coming years.

Top manufactures of Digital PCR Market are:

  • Qiagen
  • JN Medsys
  • Merck KGaA
  • Fluidign Corporation
  • Stilla Technologies
  • Thermo Fisher Scientific Inc.
  • Sysmex Inostics
  • Bio-Rad Laboratories Inc.
  • Other Players

Comments are closed